SCHEMBL27920060

SCHEMBL27920060

C=CC(N1CCN(c2cccc(C(F)(F)F)c2)CC1)S(=O)(=O)c1ccc(NC(=O)NCc2cccnc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 19/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28805763 0.92 NAMPT (0.62) NAMPT
SCHEMBL27920084 0.90 NAMPT (0.59) NAMPT
SCHEMBL27938499 0.89 NAMPT (0.56) NAMPT
SCHEMBL27920096 0.89 NAMPT (0.70) NAMPT
SCHEMBL27920067 0.89 NAMPT (0.62) NAMPT
SCHEMBL27920062 0.87 NAMPT (0.57) NAMPT
SCHEMBL27920074 0.86 NAMPT (0.60) NAMPT
SCHEMBL27938720 0.86 NAMPT (0.53) NAMPT
SCHEMBL27938640 0.86 NAMPT (0.59) NAMPT
SCHEMBL27920097 0.86 NAMPT (0.60) NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103270023-A 4- { [ (pyridin-3-yl-methyl) aminocarbonyl ] amino } benzene-sulfone derivatives as NAMPT inhibitors for the treatment of diseases such as cancer FORMA THERAPEUTICS INC 2013-08-28 CN claimed